Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 273 - 280 of 12141 results

Between the Biotech Waves Conversation with William Hicks
April 16, 2025| Podcast| Viewpoint

Canada's Federal Election 2025 — A Tale of Two Tax Policies
April 16, 2025| Alert| Viewpoint

Calling All De-Regulators: FTC Issues Request for Public Comment on Reducing Anti-Competitive Regulatory Barriers
April 15, 2025| Alert| Viewpoint

Regulation, Enforcement, and Associated Challenges: Part II
April 15, 2025| Blog| Viewpoint

401k Plan Sponsor Questions Most Forget to Ask
April 15, 2025| News

'Continuing the Trend': Mintz Tops $700M in Revenue, Sees PEP Surge 22.2%
April 14, 2025| News

HHS Restructuring and Workforce Reductions – Key Implications for the Health Care Industry
April 14, 2025| Blog| Viewpoint

Federal Energy Policy Update: A Tumultuous Start to 2025
April 14, 2025| News
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts

Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|

Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
